Year-over-year earnings per share growth for the last twelve months: Illumina, Inc. (ILMN)

Official company branding of Illumina Platform (ILMN)

Illumina, Inc. (ILMN) generates revenue through the supply of high-cost equipment and consumables to pharmaceutical behemoths and research institutes. The quarterly EPS growth trajectory visualizes the impact of implementing automated DNA analysis systems that eliminate manual labor. The current value of 46.90 captures the metric level, although the company's patent superiority is currently mitigating pressure from antitrust authorities and internal structural changes.

Illumina (ILMN) - Year-over-year net earnings per share change for the last twelve months from 07/04/2022 to 11/17/2026

Financial and market metric breakdowns for Illumina (ILMN)

- share price and expert price forecast:
- company stock exchange capitalization indicators:
Initial company analysis:Illumina, Inc.
Manufactured product of illumina.com

This indicator captures the percentage change in earnings per share (EPS) over the last quarter. Comparing this trend with competitors allows investors to assess capital management efficiency. By analyzing the quarterly EPS growth rate on the GURU.Markets platform, one can identify phases of business acceleration or stagnation. Growth in this metric confirms the monetization of Illumina, Inc. (ILMN) technological leadership. High margins on consumables coupled with inelastic demand convert directly into profit.

Main competitors

A: Quarterly EPS earnings growth|DGX - Year-over-year net earnings per share change for the last twelve months|Year-over-year earnings per share growth for the last twelve months exactsciences.com|revvity.com (RVTY) - Year-over-year net earnings per share change for the last twelve months|Quarterly EPS earnings growth BIO|Quarterly EPS earnings growth Anbio Biotechnology Ltd (NNNN)|Sotera Health - Year-over-year net earnings per share growth for the last 12 months|Quarterly EPS earnings growth QuidelOrtho Corp QDEL|OPK - Year-over-year earnings per share growth for the last twelve months|Year-over-year earnings per one share growth for the last 12 months CDNA (caredx.com)|MRVI: Quarterly EPS earnings growth|Net earnings per share growth for the trailing year Fulgent Genetics FLGT|LAB (Standard BioTools Inc) - Quarterly EPS earnings growth|Quarterly EPS earnings growth Cytek Biosciences, Inc.|Year-over-year earnings per share growth for the last twelve months OraSure Technologies (OSUR)|XGN (Exagen) - Year-over-year earnings per one share growth for the last 12 months|Year-over-year earnings per share growth for the last twelve months MDxHealth MDXH|LUCD: Year-over-year earnings per share growth for the last 12 months|PRE - Year-over-year earnings per share growth for the last twelve months|Year-over-year earnings per one share growth for the last 12 months IMDX (Insight Molecular Diagnostics Inc)|TRIB: Quarterly EPS earnings growth|prophaselabs.com - Year-over-year earnings per one share growth for the last 12 months|Year-over-year net earnings per share growth for the last 12 months AIMD|Co-Diagnostics Corp (CODX) - Year-over-year net earnings per share change for the last twelve months|Year-over-year net earnings per share growth for the last 12 months HSCS (Heart Test Laboratories Inc.)|Year-over-year net earnings per share change for the last twelve months Biomerica Inc|Year-over-year earnings per share growth for the last twelve months cardiodiagnosticsinc.com CDIO|ONCO: Year-over-year earnings per share growth for the last 12 months|VRAX - Year-over-year earnings per share growth for the last twelve months|BJDX (Bluejay Diagnostics Inc) - Year-over-year earnings per share growth for the last 12 months|AWH: Quarterly EPS earnings growth|Accelerate Diagnostics, Inc (AXDX) - Quarterly EPS earnings growth|CNTG (CENTOGENE, N.V.) - Quarterly EPS earnings growth|Year-over-year net earnings per share growth for the last 12 months Enzo Biochem (ENZ)|Year-over-year net earnings per share growth for the last 12 months FRES (fresh2.co)|GENE - Earnings per share growth in annualized terms for the last twelve months|Year-over-year earnings per share growth for the last twelve months 23andMe Inc ME|PMD: Year-over-year earnings per share growth for the last 12 months